ProfileGDS4718 / 201303_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 96% 95% 94% 95% 94% 98% 98% 97% 94% 96% 96% 96% 97% 98% 98% 97% 95% 98% 98% 96% 96% 96% 95% 96% 95% 98% 94% 98% 95% 98% 96% 97% 94% 96% 97% 98% 97% 96% 96% 95% 96% 98% 96% 98% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.631696
GSM549102patient 115, normal, homogenized [OPG study]10.169495
GSM549104patient 119, normal, homogenized [OPG study]9.9375994
GSM549108patient 138, normal, homogenized [OPG study]10.268195
GSM549119patient 077, normal, homogenized [OPG study]10.052494
GSM549133patient 032, cancer, homogenized [OPG study]11.43298
GSM549139patient 042, cancer, homogenized [OPG study]11.62698
GSM549099patient 107, normal, homogenized [OPG study]10.752397
GSM549109patient 139, normal, homogenized [OPG study]10.050794
GSM549110patient 046, normal, homogenized [OPG study]10.520996
GSM549114patient 063, normal, homogenized [OPG study]10.826596
GSM549122patient 082, normal, homogenized [OPG study]10.564596
GSM549134patient 033, cancer, homogenized [OPG study]11.090497
GSM549136patient 036, cancer, homogenized [OPG study]11.28998
GSM549140patient 044, cancer, homogenized [OPG study]11.121298
GSM549111patient 047, normal, homogenized [OPG study]10.895697
GSM549113patient 057, normal, homogenized [OPG study]10.556795
GSM549132patient 031, cancer, homogenized [OPG study]11.157598
GSM549137patient 038, cancer, homogenized [OPG study]11.066398
GSM549142patient 047, cancer, homogenized [OPG study]10.021396
GSM549100patient 110, normal, homogenized [OPG study]10.588196
GSM549107patient 135, normal, homogenized [OPG study]10.637296
GSM549115patient 068, normal, homogenized [OPG study]10.513195
GSM549116patient 072, normal, homogenized [OPG study]10.642296
GSM549120patient 078, normal, homogenized [OPG study]10.438595
GSM549131patient 030, cancer, homogenized [OPG study]11.435998
GSM549118patient 074, normal, homogenized [OPG study]10.165894
GSM549129patient 027, cancer, homogenized [OPG study]10.881698
GSM549123patient 088, normal, homogenized [OPG study]10.464195
GSM549124patient 006, cancer, homogenized [OPG study]10.960998
GSM549126patient 015, cancer, homogenized [OPG study]10.376696
GSM549128patient 025, cancer, homogenized [OPG study]10.744497
GSM549103patient 117, normal, homogenized [OPG study]9.9790394
GSM549117patient 073, normal, homogenized [OPG study]10.964196
GSM549138patient 041, cancer, homogenized [OPG study]10.928897
GSM549141patient 045, cancer, homogenized [OPG study]11.180198
GSM549130patient 028, cancer, homogenized [OPG study]10.706597
GSM549101patient 111, normal, homogenized [OPG study]10.476696
GSM549105patient 128, normal, homogenized [OPG study]10.539596
GSM549106patient 134, normal, homogenized [OPG study]10.337995
GSM549112patient 048, normal, homogenized [OPG study]10.671496
GSM549125patient 011, cancer, homogenized [OPG study]11.172998
GSM549127patient 024, cancer, homogenized [OPG study]10.488996
GSM549135patient 035, cancer, homogenized [OPG study]11.317798